中国实用妇科与产科杂志2024，Vol.40Issue(11)：1061-1065,5.DOI:10.19538/j.fk2024110102
卵巢恶性肿瘤患者诊治中的抗凝问题
Anti-coagulation in the diagnosis and treatment of patients with ovarian malignancies
摘要
Abstract
Patients with ovarian cancer are prone to venous thromboembolism(VTE).The risk of VTE for those ovarian cancer patients who receive debulking surgeries would persist until 4 weeks after surgery.Meanwhile,chemotherapy and bevacizumab may in-crease the risk of VTE.During the process of diagnosis and treatment of ovarian cancer,predictive tools such as Caprini score,G-Caprini score and Khorana score can be used to assess the risk of VTE,so that the gy-necologic oncologists can perform stratified manage-ment,and utilize the clinical methods such as D-dimer and ultrasound to screen,find and manage VTE as early as possible,in order to reduce the harm of VTE and improve the prognosis of ovarian cancer patients.关键词
卵巢癌/静脉血栓栓塞症/预防/抗凝治疗Key words
ovarian caner/venous thromboembo-lism/prophylaxis/anticoagulation分类
医药卫生引用本文复制引用
邢一春,吴妙芳,林仲秋..卵巢恶性肿瘤患者诊治中的抗凝问题[J].中国实用妇科与产科杂志,2024,40(11):1061-1065,5.基金项目
国家自然科学基金(82403264) （82403264）
广东省基础与应用基础研究基金(2024A1515013004 （）
2023A1515012647) （）
广州市临床重大技术项目(2023P-ZD12) （2023P-ZD12）
